These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Comparison of Functional and Structural Neural Network Features in Older Adults With Depression With vs Without Apathy and Association With Response to Escitalopram: Secondary Analysis of a Nonrandomized Clinical Trial. Oberlin LE; Victoria LW; Ilieva I; Dunlop K; Hoptman MJ; Avari J; Alexopoulos GS; Gunning FM JAMA Netw Open; 2022 Jul; 5(7):e2224142. PubMed ID: 35895056 [TBL] [Abstract][Full Text] [Related]
5. Cortical Thickness of the Salience Network and Change in Apathy Following Antidepressant Treatment for Late-Life Depression. Pimontel MA; Solomonov N; Oberlin L; Kanellopoulos T; Bress JN; Hoptman MJ; Alexopoulos GS; Gunning FM Am J Geriatr Psychiatry; 2021 Mar; 29(3):241-248. PubMed ID: 32680763 [TBL] [Abstract][Full Text] [Related]
6. Improved insomnia symptoms and sleep-related next-day functioning in patients with comorbid major depressive disorder and insomnia following concomitant zolpidem extended-release 12.5 mg and escitalopram treatment: a randomized controlled trial. Fava M; Asnis GM; Shrivastava RK; Lydiard B; Bastani B; Sheehan DV; Roth T J Clin Psychiatry; 2011 Jul; 72(7):914-28. PubMed ID: 21208597 [TBL] [Abstract][Full Text] [Related]
7. Predicting 6-week treatment response to escitalopram pharmacotherapy in late-life major depressive disorder. Saghafi R; Brown C; Butters MA; Cyranowski J; Dew MA; Frank E; Gildengers A; Karp JF; Lenze EJ; Lotrich F; Martire L; Mazumdar S; Miller MD; Mulsant BH; Weber E; Whyte E; Morse J; Stack J; Houck PR; Bensasi S; Reynolds CF Int J Geriatr Psychiatry; 2007 Nov; 22(11):1141-6. PubMed ID: 17486678 [TBL] [Abstract][Full Text] [Related]
8. MRI signal hyperintensities and treatment remission of geriatric depression. Gunning-Dixon FM; Walton M; Cheng J; Acuna J; Klimstra S; Zimmerman ME; Brickman AM; Hoptman MJ; Young RC; Alexopoulos GS J Affect Disord; 2010 Nov; 126(3):395-401. PubMed ID: 20452031 [TBL] [Abstract][Full Text] [Related]
9. Memantine for late-life depression and apathy after a disabling medical event: a 12-week, double-blind placebo-controlled pilot study. Lenze EJ; Skidmore ER; Begley AE; Newcomer JW; Butters MA; Whyte EM Int J Geriatr Psychiatry; 2012 Sep; 27(9):974-80. PubMed ID: 22173933 [TBL] [Abstract][Full Text] [Related]
10. Efficacy and tolerability of escitalopram versus citalopram in major depressive disorder: a 6-week, multicenter, prospective, randomized, double-blind, active-controlled study in adult outpatients. Yevtushenko VY; Belous AI; Yevtushenko YG; Gusinin SE; Buzik OJ; Agibalova TV Clin Ther; 2007 Nov; 29(11):2319-32. PubMed ID: 18158074 [TBL] [Abstract][Full Text] [Related]
11. Apathy in late-life depression among Taiwanese patients. Lee SH; Wen MC; Chao CC; Chen YJ; Yen CF Int Psychogeriatr; 2008 Apr; 20(2):328-37. PubMed ID: 17651525 [TBL] [Abstract][Full Text] [Related]
12. Effective dose of escitalopram in moderate versus severe DSM-IV major depression. Bech P; Andersen HF; Wade A Pharmacopsychiatry; 2006 Jul; 39(4):128-34. PubMed ID: 16871468 [TBL] [Abstract][Full Text] [Related]
13. Cognitive function, functional performance and severity of depression in Chinese older persons with late-onset depression. Tam CW; Lam LC East Asian Arch Psychiatry; 2012 Mar; 22(1):12-7. PubMed ID: 22447800 [TBL] [Abstract][Full Text] [Related]
14. Comparing engage with PST in late-life major depression: a preliminary report. Alexopoulos GS; Raue PJ; Kiosses DN; Seirup JK; Banerjee S; Arean PA Am J Geriatr Psychiatry; 2015 May; 23(5):506-13. PubMed ID: 25081818 [TBL] [Abstract][Full Text] [Related]
15. Do equivalent doses of escitalopram and citalopram have similar efficacy? A pooled analysis of two positive placebo-controlled studies in major depressive disorder. Lepola U; Wade A; Andersen HF Int Clin Psychopharmacol; 2004 May; 19(3):149-55. PubMed ID: 15107657 [TBL] [Abstract][Full Text] [Related]
16. A randomized, double-blind, 24-week study of escitalopram (10 mg/day) versus citalopram (20 mg/day) in primary care patients with major depressive disorder. Colonna L; Andersen HF; Reines EH Curr Med Res Opin; 2005 Oct; 21(10):1659-68. PubMed ID: 16238906 [TBL] [Abstract][Full Text] [Related]
17. Open-label treatment with desvenlafaxine in postmenopausal women with major depressive disorder not responding to acute treatment with desvenlafaxine or escitalopram. Soares CN; Thase ME; Clayton A; Guico-Pabia CJ; Focht K; Jiang Q; Kornstein SG; Ninan PT; Kane CP CNS Drugs; 2011 Mar; 25(3):227-38. PubMed ID: 21323394 [TBL] [Abstract][Full Text] [Related]
18. Double-blind comparison of escitalopram and duloxetine in the acute treatment of major depressive disorder. Khan A; Bose A; Alexopoulos GS; Gommoll C; Li D; Gandhi C Clin Drug Investig; 2007; 27(7):481-92. PubMed ID: 17563128 [TBL] [Abstract][Full Text] [Related]